CBZ

DRUG3 trials

Sponsors

ViiV Healthcare, Merck Sharp & Dohme LLC, Yuanyuan Wu

Conditions

HealthyInfection, Human Immunodeficiency VirusTrigeminal Neuralgia

Phase 1

Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects

CompletedNCT01967771

ViiV HealthcareInfection, Human Immunodeficiency Virus

Start: 2013-10-31End: 2014-01-31Updated: 2014-01-27

A Study of Carbamazepine (CBZ) and MK-8527 in Healthy Adult Participants (MK-8527-012)

CompletedNCT06893081

Merck Sharp & Dohme LLCHealthy

Start: 2025-04-28End: 2025-07-17Updated: 2025-07-29

Unknown Phase

The Synergism and Attenuation Effects of Electroacupuncture in the Treatment of Trigeminal Neuralgia

Not yet recruitingNCT07074561

Yuanyuan WuTrigeminal Neuralgia

Start: 2025-07-20End: 2025-12-31Target: 28Updated: 2025-07-20

Related Papers

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation.

2016-02-2222 citations